These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 16033747

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Psychometric performance of the National Eye Institute visual function questionnaire in Latinos and non-Latinos.
    Baker RS, Bazargan M, Calderón JL, Hays RD.
    Ophthalmology; 2006 Aug; 113(8):1363-71. PubMed ID: 16877075
    [Abstract] [Full Text] [Related]

  • 3. Baseline characteristics, the 25-Item National Eye Institute Visual Functioning Questionnaire, and their associations in the Complications of Age-Related Macular Degeneration Prevention Trial (CAPT).
    Maguire M, Complications of Age-Related Macular Degeneration Prevention Trial Research Group.
    Ophthalmology; 2004 Jul; 111(7):1307-16. PubMed ID: 15234130
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial.
    Cole SR, Beck RW, Moke PS, Gal RL, Long DT.
    Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1017-21. PubMed ID: 10752936
    [Abstract] [Full Text] [Related]

  • 10. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER.
    Broman AT, Munoz B, Rodriguez J, Sanchez R, Quigley HA, Klein R, Snyder R, West SK.
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3393-8. PubMed ID: 12407148
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment and vision-related quality of life in the early manifest glaucoma trial.
    Hyman LG, Komaroff E, Heijl A, Bengtsson B, Leske MC, Early Manifest Glaucoma Trial Group.
    Ophthalmology; 2005 Sep; 112(9):1505-13. PubMed ID: 16019074
    [Abstract] [Full Text] [Related]

  • 13. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.
    Dong LM, Childs AL, Mangione CM, Bass EB, Bressler NM, Hawkins BS, Marsh MJ, Miskala P, Jaffee HA, McCaffrey LA, Submacular Surgery Trials Research Group.
    Am J Ophthalmol; 2004 Jul; 138(1):91-108. PubMed ID: 15234287
    [Abstract] [Full Text] [Related]

  • 14. Vision-related quality of life in patients with bilateral severe age-related macular degeneration.
    Cahill MT, Banks AD, Stinnett SS, Toth CA.
    Ophthalmology; 2005 Jan; 112(1):152-8. PubMed ID: 15629836
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
    Bradley EA, Sloan JA, Novotny PJ, Garrity JA, Woog JJ, West SK.
    Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
    [Abstract] [Full Text] [Related]

  • 16. Development of a Chinese version of the National Eye Institute Visual Function Questionnaire (CHI-VFQ-25) as a tool to study patients with eye diseases in Hong Kong.
    Chan CW, Wong D, Lam CL, McGhee S, Lai WW.
    Br J Ophthalmol; 2009 Nov; 93(11):1431-6. PubMed ID: 19515645
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Validation and test characteristics of a 10-item neuro-ophthalmic supplement to the NEI-VFQ-25.
    Raphael BA, Galetta KM, Jacobs DA, Markowitz CE, Liu GT, Nano-Schiavi ML, Galetta SL, Maguire MG, Mangione CM, Globe DR, Balcer LJ.
    Am J Ophthalmol; 2006 Dec; 142(6):1026-35. PubMed ID: 17046704
    [Abstract] [Full Text] [Related]

  • 19. Development of the 25-item National Eye Institute Visual Function Questionnaire.
    Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD, National Eye Institute Visual Function Questionnaire Field Test Investigators.
    Arch Ophthalmol; 2001 Jul; 119(7):1050-8. PubMed ID: 11448327
    [Abstract] [Full Text] [Related]

  • 20. Responsiveness of NEI VFQ-25 to changes in visual acuity in neovascular AMD: validation studies from two phase 3 clinical trials.
    Suñer IJ, Kokame GT, Yu E, Ward J, Dolan C, Bressler NM.
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3629-35. PubMed ID: 19255158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.